4 research outputs found
Neutraling antibodies reduce MxA protein induction in interferon beta-1a-treated MS patients
No full textSimvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study):a placebo-controlled randomized phase 4 trial
No full text
Randomized trial of oral teriflunomide for relapsing multiple sclerosis
No full textTeriflunomide is a new oral disease-modifying therapy for relapsing forms of multiple sclerosis
